Literature DB >> 15169566

Substance use during pregnancy: time for policy to catch up with research.

Barry M Lester1, Lynne Andreozzi, Lindsey Appiah.   

Abstract

The phenomenon of substance abuse during pregnancy has fostered much controversy, specifically regarding treatment vs. punishment. Should the pregnant mother who engages in substance abuse be viewed as a criminal or as someone suffering from an illness requiring appropriate treatment? As it happens, there is a noticeably wide range of responses to this matter in the various states of the United States, ranging from a strictly criminal perspective to one that does emphasize the importance of the mother's treatment. This diversity of dramatically different responses illustrates the failure to establish a uniform policy for the management of this phenomenon. Just as there is lack of consensus among those who favor punishment, the same lack of consensus characterizes those states espousing treatment. Several general policy recommendations are offered here addressing the critical issues. It is hoped that by focusing on these fundamental issues and ultimately detailing statistics, policymakers throughout the United States will consider the course of action that views both pregnant mother and fetus/child as humanely as possible.

Entities:  

Year:  2004        PMID: 15169566      PMCID: PMC419718          DOI: 10.1186/1477-7517-1-5

Source DB:  PubMed          Journal:  Harm Reduct J        ISSN: 1477-7517


  120 in total

1.  Increasing access and providing social services to improve drug abuse treatment for women with children.

Authors:  J C Marsh; T A D'Aunno; B D Smith
Journal:  Addiction       Date:  2000-08       Impact factor: 6.526

2.  Fetal rights and the prosecution of women for using drugs during pregnancy.

Authors:  N D Janssen
Journal:  Drake Law Rev       Date:  2000

Review 3.  Drug addiction and pregnancy: policy crossroads.

Authors:  W Chavkin
Journal:  Am J Public Health       Date:  1990-04       Impact factor: 9.308

4.  Interpreting research on prenatal substance exposure in the context of multiple confounding factors.

Authors:  L L LaGasse; R Seifer; B M Lester
Journal:  Clin Perinatol       Date:  1999-03       Impact factor: 3.430

5.  Prenatal substance exposure: effects on attention and impulsivity of 6-year-olds.

Authors:  S L Leech; G A Richardson; L Goldschmidt; N L Day
Journal:  Neurotoxicol Teratol       Date:  1999 Mar-Apr       Impact factor: 3.763

Review 6.  Methodological issues in the assessment of the mother-child interactions of substance-abusing women and their children.

Authors:  D R Griffith; C Freier
Journal:  NIDA Res Monogr       Date:  1992

7.  Psychopathology in hospitalized alcoholics.

Authors:  M N Hesselbrock; R E Meyer; J J Keener
Journal:  Arch Gen Psychiatry       Date:  1985-11

8.  Meconium analysis for improved identification of infants exposed to cocaine in utero.

Authors:  R M Ryan; C L Wagner; J M Schultz; J Varley; J DiPreta; D M Sherer; D L Phelps; T Kwong
Journal:  J Pediatr       Date:  1994-09       Impact factor: 4.406

9.  A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy.

Authors:  W E Wingert; M S Feldman; M H Kim; L Noble; I Hand; J J Yoon
Journal:  J Forensic Sci       Date:  1994-01       Impact factor: 1.832

10.  The impact of drug-exposed children on family foster care.

Authors:  T McNichol
Journal:  Child Welfare       Date:  1999 Jan-Feb
View more
  46 in total

1.  Neonatal outcomes and mental illness, substance abuse, and intentional injury during pregnancy.

Authors:  Anna Wiencrot; Angela Nannini; Susan E Manning; Joan Kennelly
Journal:  Matern Child Health J       Date:  2012-07

2.  Depressive symptoms, substance abuse, and intimate partner violence among pregnant women of diverse ethnicities.

Authors:  Kisha B Holden; Robetta McKenzie; Vikki Pruitt; Katrina Aaron; Stephanie Hall
Journal:  J Health Care Poor Underserved       Date:  2012-02

3.  Substance-abusing mothers and fathers' willingness to allow their children to receive mental health treatment.

Authors:  Michelle L Kelley; Gabrielle M D'Lima; James M Henson; Cayla Cotten
Journal:  J Subst Abuse Treat       Date:  2014-03-06

4.  Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study.

Authors:  Amelia M Arria; Chris Derauf; Linda L Lagasse; Penny Grant; Rizwan Shah; Lynne Smith; William Haning; Marilyn Huestis; Arthur Strauss; Sheri Della Grotta; Jing Liu; Barry Lester
Journal:  Matern Child Health J       Date:  2006-01-05

5.  Race/ethnicity and nativity differences in alcohol and tobacco use during pregnancy.

Authors:  Krista M Perreira; Kalena E Cortes
Journal:  Am J Public Health       Date:  2006-07-27       Impact factor: 9.308

6.  Factors associated with treatment retention in pregnant women with opioid use disorders prescribed methadone or electing non-pharmacological treatment.

Authors:  Brandi Jancaitis; Sydney Kelpin; Saba Masho; James May; Nancy A Haug; Dace Svikis
Journal:  Women Health       Date:  2019-05-08

Review 7.  Effects of prenatal methamphetamine exposure: a review of cognitive and neuroimaging studies.

Authors:  Maja A Kwiatkowski; Annerine Roos; Dan J Stein; Kevin G F Thomas; Kirsty Donald
Journal:  Metab Brain Dis       Date:  2013-12-28       Impact factor: 3.584

Review 8.  Structural stigma: Research evidence and implications for psychological science.

Authors:  Mark L Hatzenbuehler
Journal:  Am Psychol       Date:  2016-11

9.  Behavioral Couples Treatment for Substance Use Disorder: Secondary Effects on the Reduction of Youth Internalizing Symptoms.

Authors:  Michelle L Kelley; Adrian J Bravo; Abby L Braitman
Journal:  J Abnorm Child Psychol       Date:  2017-05

10.  Effects of prenatal cocaine exposure on infant reactivity and regulation.

Authors:  Rina D Eiden; Shannon McAuliffe; Lorig Kachadourian; Claire Coles; Craig Colder; Pamela Schuetze
Journal:  Neurotoxicol Teratol       Date:  2008-09-10       Impact factor: 3.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.